NCT04069325 is a NA clinical trial of simiaowan in Gout Flare, sponsored by Guang'anmen Hospital of China Academy of Chinese Medical Sciences.

Who is sponsoring NCT04069325?

NCT04069325 is sponsored by Guang'anmen Hospital of China Academy of Chinese Medical Sciences.

What drugs are being tested in NCT04069325?

Interventions in NCT04069325: simiaowan, placebo, febuxostat.

What condition does NCT04069325 study?

NCT04069325 studies Gout Flare.

Is NCT04069325 still recruiting?

NCT04069325 is currently status unknown. Last updated 30 August 2019.

Last reviewed 2019-08-30 · How we verify

NCT04069325

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Efficacy and Safety of Simiaowan in Prevention of Acute Flares in Chronic Gout Patients Initiating Febuxostat Therapy

Status unknown NA Last updated 30 August 2019

What this trial tests

NA trial testing simiaowan in Gout Flare in 72 participants. Status unknown.

Timeline

1 September 2019

Primary endpoint
28 July 2020

28 July 2020

Quick facts

Lead sponsor	Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	prevention
Enrollment	72
Start date	1 September 2019
Primary completion	28 July 2020
Estimated completion	28 July 2020
Sites	1 location across China

Drugs / interventions tested

simiaowan — full drug profile →
placebo
febuxostat (FEBUXOSTAT) — full drug profile →

Conditions studied

Gout Flare — all drugs for Gout Flare →

Sponsor

Guang'anmen Hospital of China Academy of Chinese Medical Sciences

Who can join

Adults 18 to 75, any sex, with Gout Flare. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to evaluate the efficacy and safety of simiaowan in prevention of acute flares in chronic gout patients initiating febuxostat therapy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Gout Flare

Currently open trials in the same condition.

NCT07346079 — Purified Cortrophin® Gel Efficacy and Safety Study of 2 Dose Levels in Patients With Acute Gout Flares · Phase 4 · recruiting
NCT05658575 — Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare · Phase 2, PHASE3 · recruiting

Other Guang'anmen Hospital of China Academy of Chinese Medical Sciences trials

Trials by the same sponsor.

NCT07324148 — Acupuncture for Erectile Dysfunction · NA · not yet recruiting
NCT07183813 — Acupuncture for Anxiety/Depression in Patients With Breast Cancer · NA · not yet recruiting
NCT07150234 — Effectiveness of Acupuncture for Cervical Spondylotic Radiculopathy · NA · not yet recruiting
NCT06996210 — Effect of Acupuncture on Chronic Nonspecific Neck Pain and Insomnia · NA · not yet recruiting
NCT07079072 — Acupuncture for Lung Cancer-Related Fatigue · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04069325 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Last refreshed: 30 August 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04069325.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing